Welcome to
Epitope.us

    BEAVERTON, Ore., May 13 /PRNewswire/ -- Epitope, Inc.(Nasdaq: EPTO) and
LabOne, Inc. announced today that the two companies have signed an agreement
for LabOne to provide oral fluid testing for HIV to Epitope's customers in the
public health, corrections, military and college health markets using
Epitope's OraSure(R) device.  This agreement is an expansion of the two
companies' current relationship in which LabOne performs substantial volumes
of oral fluid HIV testing with Epitope's device in its insurance testing
division.
    This product offering will include: a prepackaged kit containing the
OraSure device, a requisition form and information about HIV testing, and
materials needed to express ship the sample back to LabOne for testing.
Epitope's sales representatives will market the OraSure device and the LabOne
testing service in these markets.
    "This is an important development in allowing Epitope to reach customers
who require quick reliable turnaround on test results, or are too small to
have their own labs," said John W. Morgan, president and CEO of Epitope. "This
program has already been successfully implemented, with a very positive
response from the customers who have used this service."
    "We are pleased to provide diagnostic program management services for
Epitope in these markets," said W. Thomas Grant, chairman, president and CEO
of LabOne.  "With this account, we will manage kit assembly, distribution,
testing and reporting of results for Epitope.  This is an exciting opportunity
for LabOne to expand the services we provide."
    Epitope is an Oregon-based corporation that develops and markets medical
diagnostic products.  Its principal products, including the OraSure oral
specimen collection device, focus on the use of oral fluid to detect HIV
infection and other conditions, and are marketed primarily in the life
insurance and public health sectors.
    LabOne markets clinical, substance abuse and insurance laboratory testing
services in the United States and Canada.

Source: EPITOPE Inc.

Content of this page is copyright and reprinted here for educational and historical information.
Copyright © 2004 - 2018 - Ekim Notnud - All rights Reserved
This site is an unofficial historical site and not affiliated with Epitope, Inc.